Literature DB >> 33751221

Hippocampal subfields atrophy contribute more to cognitive impairment in middle-aged patients with type 2 diabetes rather than microvascular lesions.

Wen Zhang1, Cailiang Gao2, Zhao Qing1, Zhou Zhang3, Yan Bi3, Wenbing Zeng4, Bing Zhang5.   

Abstract

AIMS: Neurodegeneration and microvascular lesions are related to cognitive impairment in type 2 diabetes mellitus (T2DM). We aimed to use the volume of hippocampal subfields and the burden of white matter hyperintensities (WMH) as neurodegeneration and microangiopathy markers, respectively, to investigate their potential associations with cognitive impairment in T2DM patients.
METHODS: A total of 76 T2DM patients and 45 neurologically unimpaired normal controls were enrolled between February 2016 to August 2018. All participants underwent structural magnetic resonance imaging (MRI) and Montreal Cognitive Assessment (MoCA). The T2DM patients were divided into the T2DM without mild cognitive impairment (T2noMCI) group (n = 44) and the T2DM with mild cognitive impairment (T2MCI) group (n = 32) according to MoCA scores. We used automatic brain segmentation and quantitative technique to assess the volume of twelve hippocampal subfields and WMH on MRI. We used age, sex, education, and total intracranial volume as our covariates and the Bonferroni method for multiple comparison correction.
RESULTS: Both the T2MCI group and T2noMCI group showed significant hippocampal subfields atrophy compared to the controls, which were mainly in the left hippocampal tail, left CA1, bilateral molecular layer, bilateral dentate gyrus, and bilateral CA4 (all p < 0.0042). No significant differences in the volume of total WMH, deep-WMH, and periventricular-WMH were found among the three groups. The HbA1c levels were significantly negatively correlated with hippocampal atrophy, and the MoCA scores were positively correlated with bilateral hippocampal volume in T2DM patients and all samples. Mediation analyses demonstrated that the association of HbA1c levels with cognitive function was mediated by hippocampal subfields volume.
CONCLUSION: Widespread hippocampal atrophies across the subfields have been found in middle-aged T2DM patients, which was positively correlated with the MoCA scores and negatively correlated with the HbA1c levels. The association of HbA1c levels with cognitive function was mediated by some crucial hippocampal subfields volume. In middle-aged patients with T2DM, the neurodegeneration is more strongly associated with cognitive impairment than microvascular lesions. Trail Registeration This study was registered on Clinical-Trails.gov (NCT02738671).
© 2021. Springer-Verlag Italia S.r.l., part of Springer Nature.

Entities:  

Keywords:  Cognitive impairment; Hippocampal subfields; Type 2 diabetes mellitus; White matter hyperintensities

Year:  2021        PMID: 33751221     DOI: 10.1007/s00592-020-01670-x

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  37 in total

Review 1.  Cognitive function in patients with diabetes mellitus: guidance for daily care.

Authors:  Paula S Koekkoek; L Jaap Kappelle; Esther van den Berg; Guy E H M Rutten; Geert Jan Biessels
Journal:  Lancet Neurol       Date:  2015-02-16       Impact factor: 44.182

Review 2.  Advanced glycation end-products produced systemically and by macrophages: A common contributor to inflammation and degenerative diseases.

Authors:  Kyunghee Byun; YongCheol Yoo; Myeongjoo Son; Jaesuk Lee; Goo-Bo Jeong; Young Mok Park; Ghasem Hosseini Salekdeh; Bonghee Lee
Journal:  Pharmacol Ther       Date:  2017-02-13       Impact factor: 12.310

Review 3.  Central nervous pathways of insulin action in the control of metabolism and food intake.

Authors:  Stephanie Kullmann; André Kleinridders; Dana M Small; Andreas Fritsche; Hans-Ulrich Häring; Hubert Preissl; Martin Heni
Journal:  Lancet Diabetes Endocrinol       Date:  2020-06       Impact factor: 32.069

Review 4.  Islet amyloid polypeptide, islet amyloid, and diabetes mellitus.

Authors:  Per Westermark; Arne Andersson; Gunilla T Westermark
Journal:  Physiol Rev       Date:  2011-07       Impact factor: 37.312

Review 5.  Diabetes and cognitive dysfunction.

Authors:  Rory J McCrimmon; Christopher M Ryan; Brian M Frier
Journal:  Lancet       Date:  2012-06-09       Impact factor: 79.321

6.  Hippocampal damage and memory impairments as possible early brain complications of type 2 diabetes.

Authors:  S M Gold; I Dziobek; V Sweat; A Tirsi; K Rogers; H Bruehl; W Tsui; S Richardson; E Javier; A Convit
Journal:  Diabetologia       Date:  2007-02-14       Impact factor: 10.122

7.  Hippocampal atrophy rates in Alzheimer disease: added value over whole brain volume measures.

Authors:  W J P Henneman; J D Sluimer; J Barnes; W M van der Flier; I C Sluimer; N C Fox; P Scheltens; H Vrenken; F Barkhof
Journal:  Neurology       Date:  2009-03-17       Impact factor: 9.910

8.  Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons.

Authors:  Alexis M Stranahan; Thiruma V Arumugam; Roy G Cutler; Kim Lee; Josephine M Egan; Mark P Mattson
Journal:  Nat Neurosci       Date:  2008-02-17       Impact factor: 24.884

9.  Modifiers of cognitive function and brain structure in middle-aged and elderly individuals with type 2 diabetes mellitus.

Authors:  Hannah Bruehl; Oliver T Wolf; Victoria Sweat; Aziz Tirsi; Stephen Richardson; Antonio Convit
Journal:  Brain Res       Date:  2009-05-20       Impact factor: 3.252

Review 10.  Diabetes and the brain: oxidative stress, inflammation, and autophagy.

Authors:  María Muriach; Miguel Flores-Bellver; Francisco J Romero; Jorge M Barcia
Journal:  Oxid Med Cell Longev       Date:  2014-08-24       Impact factor: 6.543

View more
  1 in total

1.  Association between Type 2 Diabetes Mellitus and Brain Atrophy: A Meta-Analysis (Diabetes Metab J 2022;46:781-802).

Authors:  Se Hee Min
Journal:  Diabetes Metab J       Date:  2022-09-19       Impact factor: 5.893

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.